Disc Medicine
IRON
62 hedge funds and large institutions have $93.8M invested in Disc Medicine in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 13 closing their positions.
246% more call options, than puts
Call options by funds: $211K | Put options by funds: $61K
0.51% more ownership
Funds ownership: 1.98% → 2.49% (+0.51%)
0% more funds holding
Funds holding: 62 → 62 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
9% less capital invested
Capital invested by funds: $103M → $93.8M (-$9.7M)
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
+$766K |
| 2 |
Goldman Sachs
New York
|
+$189K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$171K |
| 4 |
Jane Street
New York
|
+$122K |
| 5 |
PCM
Prelude Capital Management
New York
|
+$107K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.55M |
| 2 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$1.15M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$759K |
| 4 |
AI
Atom Investors
Austin,
Texas
|
-$415K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$378K |
IRON Hedge Fund Activity: Q4 2021 in Review
62 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Disc Medicine (IRON) for Q4 2021, worth a combined $93.8M — down 9.4% from $103M a quarter earlier.
Fund positioning in IRON was balanced in Q4 2021: 13 funds opened new positions, 13 closed out, 16 added to existing stakes and 18 trimmed.
The largest buyer was Suvretta Capital Management, adding an estimated $766K. The largest seller was Vanguard Group, cutting an estimated $1.55M.
- 62 institutional investors held Disc Medicine (IRON) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $93.8M of Disc Medicine stock for Q4 2021, down 9.4% quarter-over-quarter.
- 13 funds opened new Disc Medicine positions in Q4 2021 and 13 closed out, a net change of 0 holders.
- The largest Disc Medicine buyer in Q4 2021 was Suvretta Capital Management, an estimated $766K added.
- The largest Disc Medicine seller in Q4 2021 was Vanguard Group, an estimated $1.55M sold.
Based on aggregated 13F filings for Q4 2021.